findmyKOL

Melinda Telli, MD

Enriched profile

Professor of Medicine, Stanford University · Stanford University School of Medicine

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Stanford, CA · West · United StatesSpecialtyMedical OncologyFocusBreast Cancer Treatment Studies+4
Active KOLfindmyKOL type: EliteLatest publication2026Online presenceverified 2026Payments2021–2025NIH funding2026–2026

Melinda Telli is Professor of Medicine, Stanford University at Stanford University School of Medicine. OpenAlex indexes 365 publications with 19,475 citations (h-index 58); ClinicalTrials.gov lists 8 registered studies with this person as an investigator.

Data verified 23 Oct 2026

Overview

Updated 23 Oct 2026

Melinda Telli, MD, is Professor of Medicine, Stanford University at Stanford University School of Medicine (Division of Medical Oncology). The public record shows 365 publications with 19,475 citations (h-index 58), centered on Breast Cancer Treatment Studies, BRCA gene mutations in cancer, PARP inhibition in cancer therapy. It also documents an investigator role on 8 registered clinical trials, industry payments reported by 20 companies, 1 NIH-funded awards (2026–2026).

  • Most recent indexed publication: 2026 · Journal of clinical oncology
  • Top research focus: Breast Cancer Treatment Studies
  • 8 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 20 companies

Generated from the cited public record · current as of 23 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Breast Cancer8 trials

Research focus

OpenAlex concept fingerprint
Breast Cancer Treatment StudiesBRCA gene mutations in cancerPARP inhibition in cancer therapyCancer Immunotherapy and BiomarkersAdvanced Breast Cancer Therapies

Drugs & molecules

across trials, industry payments and publications
Keytrudageneric · PembrolizumabClinical trials2Industry payments2Publications2Enhertugeneric · TrastuzumabClinical trials—Industry payments10Publications3PaclitaxelClinical trials1Industry payments—Publications4CarboplatinClinical trials1Industry payments—Publications3Lynparzageneric · OlaparibClinical trials—Industry payments3Publications1Tecentriqgeneric · AtezolizumabClinical trials—Industry payments1Publications3DoxorubicinClinical trials1Industry payments—Publications1Perjetageneric · PertuzumabClinical trials—Industry payments1Publications1Ibrancegeneric · PalbociclibClinical trials—Industry payments8Publications—Trodelvygeneric · SacituzumabClinical trials—Industry payments5Publications—Kisqaligeneric · RibociclibClinical trials—Industry payments2Publications—Orserdugeneric · ElacestrantClinical trials—Industry payments2Publications—

Works with

trial sponsors and companies reporting payments
AstraZeneca Pharmaceuticals LPClinical trials—Industry payments23Eli Lilly and CompanyClinical trials—Industry payments15Gilead Sciences, Inc.Clinical trials—Industry payments9Pfizer Inc.Clinical trials—Industry payments9RefleXion Medical, Inc.Clinical trials—Industry payments6Daiichi Sankyo Inc.Clinical trials—Industry payments5AstraZeneca UK LimitedClinical trials—Industry payments4Stanford UniversityClinical trials4Industry payments—Blueprint Medicines CorporationClinical trials—Industry payments3Genentech USA, Inc.Clinical trials—Industry payments3Merck Sharp & Dohme LLCClinical trials—Industry payments3Genentech, Inc.Clinical trials—Industry payments2GlaxoSmithKline, LLC.Clinical trials—Industry payments2Melinda TelliClinical trials2Industry payments—Merck Sharp & Dohme CorporationClinical trials—Industry payments2Novartis Pharmaceuticals CorporationClinical trials—Industry payments2Stemline Therapeutics Inc.Clinical trials—Industry payments2Alliance for Clinical Trials in OncologyClinical trials1Industry payments—BioNTech SEClinical trials—Industry payments1F. Hoffmann-La Roche AGClinical trials—Industry payments1G1 Therapeutics, Inc.Clinical trials—Industry payments1Genzyme CorporationClinical trials—Industry payments1Lilly USA, LLCClinical trials—Industry payments1SWOG Cancer Research NetworkClinical trials1Industry payments—

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
365publications

Distinct works indexed by OpenAlex, matched via ORCID; 10 in PubMed.

19,475citations

Total citations across indexed works.

58h-index

Hirsch index (OpenAlex). i10-index 130.

Clinical & industry

trials, payments and federal funding
8clinical trials

Investigator role on registered studies.

View trials ↓
20companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
1NIH grants · 2026–2026

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 23 Oct 2026

Listed as an investigator on 8 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 23 Oct 2026

20 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cancer & immunology

    100%
    Aromatase Inhibitor100%
    Letrozole100%
    Part D<11 patients
Where care is delivered (Part B)88.4% facility · 11.6% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 23 Oct 2026

1 NIH research award on record, funded 2026–2026 per NIH RePORTER. The latest:

Congress activity

Updated 23 Oct 2026

106 congress contributions (2008–2026) across AACR, ASCO, ASTRO, ESMO, SABCS per OpenAlex. The most recent:

Publications

Updated 23 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 23 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

James M. Ford84Shaveta Vinayak49Allison W. Kurian46Irene Wapnir42Andrew N.J. Tutt35Anita E. Grigoriadis33David A. Canton33Hasan Mirza32Maggie C.U. Cheang32Donna Bannavong32Christopher G. Twitty32Christopher J. Lord31Mai Hope Le30Kellie Malloy Foerter30Kaitlin Zablotsky30Erica Browning29Lauren Svenson29Reneta Hermiz29Hope S. Rugo29Herbert Kim Lyerly28Erika J. Crosby28Chaitanya R. Acharya28Hiroshi Nagata28Takuya Osada28Jendy Sell27Kim Jaffe26Shawn M. Jensen26Steven Jay Isakoff26Carmen Ballesteros‐Merino26Carlo Bruno Bifulco26Bernard A. Fox26Robert Hamilton Pierce26Joshua James Gruber24Joyce O’Shaughnessy24Matthew Philip Goetz23Kirsten M. Timms23Sara Alsterlind Hurvitz23Angela M. DeMichele21Kristin C. Jensen21Jelmar Quist21

Online presence

Updated 23 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/melinda-telli-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 23 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • Board certification

    American Board of Internal Medicine, Medical Oncology

    2018
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →stanfordhealthcare.org ↗
  • M.D.

    George Washington University

    2002
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →stanfordhealthcare.org ↗
  • B.A.

    University of Pennsylvania, Biology

    1996
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →stanfordhealthcare.org ↗

Editorial & leadership roles

journal and society appointments

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.